As a condition of Medicines Company's (MDCO +1.9%) acquisition of Incline Therapeutics, Cadence...

|About: The Medicines Company (MDCO)|By:, SA News Editor

As a condition of Medicines Company's (MDCO +1.9%) acquisition of Incline Therapeutics, Cadence Pharmaceuticals (CADX +4.9%) has agreed to terminate its exclusive option to acquire Incline. Upon MDCO's closing of the deal, CADX will receive around $13M in termination fees and roughly $1.5M for its Incline stake as well as a pro-rated share of future milestone payments.